Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 4073 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Luminex licenses rights to microRNA assays

MicroRNAs are a group of small non-coding single stranded portions of RNA molecules that have been implicated as playing a critical role as regulators of developmental timing, neuronal

FDA approves Somerset depression patch

The drug will be marketed by Bristol-Myers Squibb who obtained exclusive US distribution rights to Emsam in an agreement with Somerset made in December 2004. Emsam is the

MHRA acts on Butterflies Healthcare marketing complaint

In its marketing materials, Butterflies Healthcare claimed that its Viteyes range of dietary supplements could prevent age-related macular degeneration. The Medicines and Healthcare Products Regulatory Agency’s (MHRA) Medicines